Literature DB >> 35181590

High-throughput Proteomic Profiling of Male Breast Cancer Tissue.

Eleni Zografos1, Stavros C Proikakis2, Athanasios K Anagnostopoulos2, Anna-Maria Korakiti3, Flora Zagouri3, Maria Gazouli4, George T Tsangaris2.   

Abstract

BACKGROUND/AIM: Until now, little emphasis has been placed on the protein expression profile of male breast cancer (MBC) tumors, due to the rarity of the disease. The present study aimed to identify a proteomic pattern that is characteristic for malignant male breast tissue epithelium.
MATERIALS AND METHODS: The protein content of four male breast tumors and corresponding adjacent healthy (control) tissues was analyzed by high-throughput nano-liquid chromatography-MS/MS technology.
RESULTS: A total of 2,352 proteins were identified, that correspond to 1,249 single gene products, with diverse biological roles. Of those, a panel of 119 differentially expressed tissue proteins was identified in MBC samples compared to controls; 90 were found to be over-expressed in MBC tissues, while 29 were down-regulated. Concurrently, 844 proteins were detected only in MBC tumors and 197 were expressed exclusively in control mammary samples.
CONCLUSION: Differential proteomic expression was found in MBC tissue, leading to improved understanding of MBC pathology and highlighting the need for personalized management of male patients.
Copyright © 2022, International Institute of Anticancer Research (Dr. George J. Delinasios), All rights reserved.

Entities:  

Keywords:  HPLC-MS/MS; Male breast cancer; high resolution mass spectrometry; proteomics

Mesh:

Substances:

Year:  2022        PMID: 35181590      PMCID: PMC8865043          DOI: 10.21873/cgp.20316

Source DB:  PubMed          Journal:  Cancer Genomics Proteomics        ISSN: 1109-6535            Impact factor:   4.069


  34 in total

1.  A signalling pathway controlling c-Myc degradation that impacts oncogenic transformation of human cells.

Authors:  Elizabeth Yeh; Melissa Cunningham; Hugh Arnold; Dawn Chasse; Teresa Monteith; Giovanni Ivaldi; William C Hahn; P Todd Stukenberg; Shirish Shenolikar; Takafumi Uchida; Christopher M Counter; Joseph R Nevins; Anthony R Means; Rosalie Sears
Journal:  Nat Cell Biol       Date:  2004-03-14       Impact factor: 28.824

2.  Primary breast cancer: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up.

Authors:  E Senkus; S Kyriakides; S Ohno; F Penault-Llorca; P Poortmans; E Rutgers; S Zackrisson; F Cardoso
Journal:  Ann Oncol       Date:  2015-09       Impact factor: 32.976

3.  Cancer Statistics, 2021.

Authors:  Rebecca L Siegel; Kimberly D Miller; Hannah E Fuchs; Ahmedin Jemal
Journal:  CA Cancer J Clin       Date:  2021-01-12       Impact factor: 508.702

Review 4.  Clinical proteomics and breast cancer.

Authors:  Bashar A Zeidan; Paul A Townsend; Spiros D Garbis; Ellen Copson; Ramsey I Cutress
Journal:  Surgeon       Date:  2015-02-24       Impact factor: 2.392

5.  Proteomic profiling of lipid rafts in a human breast cancer model of tumorigenic progression.

Authors:  Joseph A Caruso; Paul M Stemmer
Journal:  Clin Exp Metastasis       Date:  2011-05-01       Impact factor: 5.150

6.  Detection of protein alterations in male breast cancer using two dimensional gel electrophoresis and mass spectrometry: the involvement of several pathways in tumorigenesis.

Authors:  Karim Chahed; Maria Kabbage; Bechr Hamrita; Christelle Lemaitre Guillier; Mounir Trimeche; Sami Remadi; Laurence Ehret-Sabatier; Lotfi Chouchane
Journal:  Clin Chim Acta       Date:  2007-10-22       Impact factor: 3.786

7.  Gene expression profiling of primary male breast cancers reveals two unique subgroups and identifies N-acetyltransferase-1 (NAT1) as a novel prognostic biomarker.

Authors:  Ida Johansson; Cecilia Nilsson; Pontus Berglund; Martin Lauss; Markus Ringnér; Håkan Olsson; Lena Luts; Edith Sim; Sten Thorstensson; Marie-Louise Fjällskog; Ingrid Hedenfalk
Journal:  Breast Cancer Res       Date:  2012-02-14       Impact factor: 6.466

8.  Filamin A regulates focal adhesion disassembly and suppresses breast cancer cell migration and invasion.

Authors:  Yingjie Xu; Tarek A Bismar; Jie Su; Bin Xu; Glen Kristiansen; Zsuzsanna Varga; Lianghong Teng; Donald E Ingber; Akiko Mammoto; Rakesh Kumar; Moulay A Alaoui-Jamali
Journal:  J Exp Med       Date:  2010-10-11       Impact factor: 14.307

9.  Determination of the protein expression profiles of breast cancer cell lines by quantitative proteomics using iTRAQ labelling and tandem mass spectrometry.

Authors:  Karla Grisel Calderón-González; Ma Luz Valero Rustarazo; Maria Luisa Labra-Barrios; César Isaac Bazán-Méndez; Alejandra Tavera-Tapia; Maria Esther Herrera-Aguirre; Manuel M Sánchez del Pino; José Luis Gallegos-Pérez; Humberto González-Márquez; Jose Manuel Hernández-Hernández; Gloria León-Ávila; Sergio Rodríguez-Cuevas; Fernando Guisa-Hohenstein; Juan Pedro Luna-Arias
Journal:  J Proteomics       Date:  2015-04-24       Impact factor: 4.044

10.  The landscape of candidate driver genes differs between male and female breast cancer.

Authors:  Ida Johansson; Markus Ringnér; Ingrid Hedenfalk
Journal:  PLoS One       Date:  2013-10-23       Impact factor: 3.240

View more
  1 in total

Review 1.  An Update on the General Features of Breast Cancer in Male Patients-A Literature Review.

Authors:  Sinziana Ionescu; Alin Codrut Nicolescu; Marian Marincas; Octavia-Luciana Madge; Laurentiu Simion
Journal:  Diagnostics (Basel)       Date:  2022-06-26
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.